Our pooled analysis did not detect significant differences in systolic or diastolic blood pressure between treatment groups, although there was a numerical trend toward lower blood pressure with roxadustat.
← all excerpts
Roxadustat for CKD-related anemia in patients undergoing peritoneal dialysis: a systematic review and meta-analysis.
1
—
—